William Andrews

William Andrews

Chief Tech/Sci/R&D Officer at CATALYST PHARMACEUTICALS, INC.

Net worth: 72 110 $ as of 2026-05-30

62 year
Health Technology
Consumer Services

Profile

William T.
Andrews
is the founder of The Aletheia Group LLC.
Dr. Andrews is Chief Medical Officer at Catalyst Pharmaceuticals, Inc. and Chief Medical Officer at Rafarma Pharmaceuticals, Inc., both starting in 2025.
Formerly, Dr. Andrews was President & Chief Executive Officer at Lighthouse Biosciences Inc., Senior Vice President-Business Development at Aegerion Pharmaceuticals, Inc. from 2014 to 2016, Chief Medical Officer at Flexion Therapeutics, Inc. in 2021, Chief Medical Officer at Akcea Therapeutics, Inc., and Chief Medical Officer at Acer Therapeutics, Inc. from 2017 to 2020.
Dr. Andrews completed undergraduate studies at Harvard University and earned a doctorate from Yale School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-02 2,309 ( 0% ) 72 110 $ 2026-05-30

William Andrews active positions

CompaniesPositionStart
CATALYST PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2025-05-31
RAFARMA PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2025-06-01

Former positions of William Andrews

CompaniesPositionEnd
FLEXION THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2021-11-18
ACER THERAPEUTICS INC. Chief Tech/Sci/R&D Officer 2020-07-07
AEGERION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2014-04-30
The Aletheia Group LLC
Founder -
Chief Executive Officer -
See the detail of William Andrews's experience

Training of William Andrews

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

45

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

The Aletheia Group LLC

  1. Stock Market
  2. Insiders
  3. William Andrews